Beers criteria

Last updated

The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, commonly called the Beers List, [1] are guidelines published by the American Geriatrics Society (AGS) for healthcare professionals to help improve the safety of prescribing medications for adults 65 years and older in all except palliative settings. [2] [3] They emphasize deprescribing medications that are unnecessary, which helps to reduce the problems of polypharmacy, drug interactions, and adverse drug reactions, thereby improving the risk–benefit ratio of medication regimens in at-risk people. [4]

Contents

The criteria are used in geriatrics clinical care to monitor and improve the quality of care. They are also used in training, research, and healthcare policy to assist in developing performance measures and document outcomes. These criteria include lists of medications in which the potential risks may be greater than the potential benefits for people 65 and older. By considering this information, practitioners may be able to reduce harmful side effects caused by such medications. The Beers Criteria are intended to serve as a guide for clinicians and not as a substitute for professional judgment in prescribing decisions. The criteria may be used in conjunction with other information to guide clinicians about safe prescribing in older adults. [5] [ non-primary source needed ] [6] [ non-primary source needed ].

The criteria are frequently used internationally although they were only intended for use in the United States. Some countries have adapted the criteria to their own context. Others countries have observed that the listed medications may not be applicable in their country. [7]

History

Geriatrician Mark H. Beers formulated the Beers Criteria through a consensus panel of experts using the Delphi method. The criteria were originally published in the Archives of Internal Medicine in 1991 [8] and updated in 1997, 2003, 2012, 2015, 2019, and 2023. [9] [10] [11] [12]

The AGS has registered a trademark for the term "AGS Beers Criteria" and in 2018, it formed a commercial partnership to authorize the release of a software application applying its official criteria. [13] [14]

Management of criteria

In 2011, the American Geriatrics Society (AGS) convened an eleven-member multidisciplinary panel of experts in geriatric medicine, nursing, and pharmacotherapy to develop the 2012 edition of the American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. [15]

The 2012 AGS Beers Criteria differ from previous editions in several ways. In addition to using a modified Delphi process for building consensus, the expert panel followed the evidence-based approach that AGS has used since it developed its first practice guideline on persistent pain in 1998.[ citation needed ] The Institute of Medicine (IOM) in its 2011 report, Clinical Practice Guidelines We Can Trust, [16] recommended that all guideline developers complete a systematic review of the evidence. Following the recommendation of the IOM, AGS added a public comment period that occurred in parallel to its standard invited external peer review process. [15] In a significant departure from previous versions of the criteria, each recommendation is rated for quality of both the evidence supporting the panel's recommendations and the strength of their recommendations.[ citation needed ]

In another departure from the 2003 criteria, the 2012 AGS Beers Criteria identify and group medications that may be inappropriate for older adults into three different categories instead of the previous two. The first category includes medications that are potentially inappropriate for older people because they either pose high risks of adverse effects or appear to have limited effectiveness in older patients, and because there are alternatives to these medications. The second category includes medications that are potentially inappropriate for older people who have certain diseases or disorders because these drugs may exacerbate the specified health problems. The third category includes medications that, although they may be associated with more risks than benefits in general, may be the best choice for a particular individual if administered with caution.[ citation needed ]

The 2012 AGS Beers Criteria was released in February 2012 via publication in the early online edition of the Journal of the American Geriatrics Society . [15]

The Beers Criteria was updated in 2019 [1] [17] and 2023. [12]

Style of the publication

Drugs listed on the Beers List are categorized according to risks for negative outcomes. The tables include medications that have cautions, should be avoided, should be avoided with concomitant medical conditions, and are contraindicated and relatively contraindicated in the elderly population. An example of an included drug is diphenhydramine (Benadryl), a first-generation H1 antagonist with anticholinergic properties, which may increase sedation and lead to confusion or falls.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Antipsychotic</span> Class of medications

Antipsychotics, also known as neuroleptics, are a class of psychotropic medication primarily used to manage psychosis, principally in schizophrenia but also in a range of other psychotic disorders. They are also the mainstay together with mood stabilizers in the treatment of bipolar disorder.

<span class="mw-page-title-main">Benzodiazepine</span> Class of depressant drugs

Benzodiazepines, colloquially called "benzos", are a class of depressant drugs whose core chemical structure is the fusion of a benzene ring and a diazepine ring. They are prescribed to treat conditions such as anxiety disorders, insomnia, and seizures. The first benzodiazepine, chlordiazepoxide (Librium), was discovered accidentally by Leo Sternbach in 1955 and was made available in 1960 by Hoffmann–La Roche, who soon followed with diazepam (Valium) in 1963. By 1977, benzodiazepines were the most prescribed medications globally; the introduction of selective serotonin reuptake inhibitors (SSRIs), among other factors, decreased rates of prescription, but they remain frequently used worldwide.

<span class="mw-page-title-main">Hypnotic</span> Drug whose use induces sleep

Hypnotic, or soporific drugs, commonly known as sleeping pills, are a class of psychoactive drugs whose primary function is to induce sleep and to treat insomnia (sleeplessness).

<span class="mw-page-title-main">Zolpidem</span> Hypnotic medication

Zolpidem, sold under the brand name Ambien among others, is a medication primarily used for the short-term treatment of sleeping problems. Guidelines recommend that it be used only after cognitive behavioral therapy for insomnia and behavioral changes, such as sleep hygiene, have been tried. It decreases the time to sleep onset by about fifteen minutes and at larger doses helps people stay asleep longer. It is taken by mouth and is available in conventional tablets, sublingual tablets, or oral spray.

<span class="mw-page-title-main">Geriatrics</span> Specialty that focuses on health care of elderly people

Geriatrics, or geriatric medicine, is a medical specialty focused on providing care for the unique health needs of the elderly. The term geriatrics originates from the Greek γέρων geron meaning "old man", and ιατρός iatros meaning "healer". It aims to promote health by preventing, diagnosing and treating disease in older adults. There is no defined age at which patients may be under the care of a geriatrician, or geriatric physician, a physician who specializes in the care of older people. Rather, this decision is guided by individual patient need and the caregiving structures available to them. This care may benefit those who are managing multiple chronic conditions or experiencing significant age-related complications that threaten quality of daily life. Geriatric care may be indicated if caregiving responsibilities become increasingly stressful or medically complex for family and caregivers to manage independently.

Antihypertensives are a class of drugs that are used to treat hypertension. Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke, heart failure, kidney failure and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34% and of ischaemic heart disease by 21%, and can reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease. There are many classes of antihypertensives, which lower blood pressure by different means. Among the most important and most widely used medications are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers.

<span class="mw-page-title-main">Nitrofurantoin</span> Antibacterial drug

Nitrofurantoin is an antibacterial medication used to treat urinary tract infections, but it is not as effective for kidney infections. It is taken by mouth.

<span class="mw-page-title-main">Polypharmacy</span> Use of five or more medications daily

Polypharmacy (polypragmasia) is an umbrella term to describe the simultaneous use of multiple medicines by a patient for their conditions. Most commonly it is defined as regularly taking five or more medicines but definitions vary in where they draw the line for the minimum number of drugs. Polypharmacy is often the consequence of having multiple long-term conditions, also known as multimorbidity. An excessive number of medications is worrisome, especially for older patients with many chronic health conditions, because this increases the risk of an adverse event in those patients.

<span class="mw-page-title-main">Adverse drug reaction</span> Medical condition

An adverse drug reaction (ADR) is a harmful, unintended result caused by taking medication. ADRs may occur following a single dose or prolonged administration of a drug or may result from the combination of two or more drugs. The meaning of this term differs from the term "side effect" because side effects can be beneficial as well as detrimental. The study of ADRs is the concern of the field known as pharmacovigilance. An adverse event (AE) refers to any unexpected and inappropriate occurrence at the time a drug is used, whether or not the event is associated with the administration of the drug. An ADR is a special type of AE in which a causative relationship can be shown. ADRs are only one type of medication-related harm. Another type of medication-related harm type includes not taking prescribed medications, which is also known as non-adherence. Non-adherence to medications can lead to death and other negative outcomes. Adverse drug reactions require the use of a medication.

<span class="mw-page-title-main">Eszopiclone</span> Hypnotic medication

Eszopiclone, sold under the brand name Lunesta among others, is a medication used in the treatment of insomnia. Evidence supports slight to moderate benefit up to six months. It is taken by mouth.

<span class="mw-page-title-main">Meloxicam</span> Nonsteroidal anti-inflammatory drug (NSAID)

Meloxicam, sold under the brand name Mobic among others, is a nonsteroidal anti-inflammatory medication (NSAID) used to treat pain and inflammation in rheumatic diseases and osteoarthritis. It is used by mouth or by injection into a vein. It is recommended that it be used for as short a period as possible and at a low dose.

<span class="mw-page-title-main">Zaleplon</span> Medication

Zaleplon, sold under the brand name Sonata among others, is a sedative and hypnotic which is used to treat insomnia. It is a nonbenzodiazepine or Z-drug of the pyrazolopyrimidine class. It was developed by King Pharmaceuticals.

<span class="mw-page-title-main">Corvalol</span> Tranquilizer based with herbs Valerian, hops, peppermint & phenobarbital, a barbiturate

Corvalol is a tranquilizer based on the herb valerian root, as well peppermint oil Mentha piperita and hop extract Humulus lupulus and the barbiturate phenobarbital, popular in Eastern Europe and the former Soviet Union as a heart medication. It is available as a transparent liquid with a characteristic strong aroma, and as white bi-concave scored tablets. While not available for sale in the Western countries, Corvalol is sometimes brought over from Eastern Europe for self-administration to other countries of residence. Corvalol contains documented amounts of psychoactive chemicals, and may interact with other prescription medications that a person is taking.

Medication discontinuation is the ceasing of a medication treatment for a patient by either the clinician or the patient themself. When initiated by the clinician, it is known as deprescribing. Medication discontinuation is an important medical practice that may be motivated by a number of reasons:

The American Geriatrics Society (AGS) is a non-profit professional society founded on June 11, 1942, for health care professionals practicing geriatric medicine. Among the founding physicians were Dr. Ignatz Leo Nascher, who coined the term "geriatrics", Dr. Malford W. Thewlis, who was named the first executive secretary of the Society, and Dr. Lucien Stark who was appointed the first AGS president.

Mark Howard Beers was an American geriatrician whose research on drug interactions among the elderly led to the creation of the eponymous Beers criteria, which lists prescription medications that may have deleterious side effects in older patients.

<span class="mw-page-title-main">Deprescribing</span> Medical condition

Deprescribing is described as a patient-centred process to taper or stop medications with the intention to achieve improved health outcomes by reducing exposure to medications that are potentially either harmful or no longer required. Deprescribing is important to consider with changing health and care goals over time, as well as polypharmacy and adverse effects. Deprescribing can improve adherence, cost, and health outcomes but may have adverse drug withdrawal effects. More specifically, deprescribing is the planned and supervised process of intentionally stopping a medication or reducing its dose to improve the person's health or reduce the risk of adverse side effects. Deprescribing is usually done because the drug may be causing harm, may no longer be helping the patient, or may be inappropriate for the individual patient's current situation. Deprescribing can help correct polypharmacy and prescription cascade.

The Medication Appropriateness Tool for Comorbid Health conditions during Dementia (MATCH-D) criteria supports clinicians to manage medication use specifically for people with dementia without focusing only on the management of the dementia itself.

<span class="mw-page-title-main">Somnifacient</span> Class of medications that induce sleep

Somnifacient, also known as sedatives or sleeping pills, is a class of medications that induces sleep. It is mainly used for treatment of insomnia. Examples of somnifacients include benzodiazepines, Barbiturates and Antihistamines.

References

  1. 1 2 "Beers Criteria Medication List". Duke Clinical Research Institute. Duke Health. Retrieved August 28, 2018.
  2. ↑ American Geriatrics Society Beers Criteria Update Expert Panel (2019-01-29). "American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults". Journal of the American Geriatrics Society. Wiley. 67 (4): 674–694. doi:10.1111/jgs.15767. ISSN   0002-8614. PMID   30693946. S2CID   59338182. The AGS Beers Criteria® is an explicit list of Potentially Inappropriate Medications (PIMs) that are typically best avoided by older adults in most circumstances or under specific situations, such as in certain diseases or conditions.
  3. ↑ Steinman, Michael A.; Beizer, Judith L.; DuBeau, Catherine E.; Laird, Rosemary D.; Lundebjerg, Nancy E.; Mulhausen, Paul (2015-10-08). "How to Use the American Geriatrics Society 2015 Beers Criteria-A Guide for Patients, Clinicians, Health Systems, and Payors". Journal of the American Geriatrics Society. Wiley. 63 (12): e1–e7. doi:10.1111/jgs.13701. ISSN   0002-8614. PMC   5325682 . PMID   26446776.
  4. ↑ American Geriatrics Society (2012). "Identifying medications that older adults should avoid or use with caution: the 2012 American Geriatrics Society updated Beers criteria". New York: Foundation for Health in Aging.
  5. ↑ Budnitz, Daniel S.; Lovegrove, Maribeth C.; Shehab, Nadine; Richards, Chesley L. (24 November 2011). "Emergency Hospitalizations for Adverse Drug Events in Older Americans". N Engl J Med. 365 (21): 2002–12. doi: 10.1056/NEJMsa1103053 . PMID   22111719. S2CID   37983506.
  6. ↑ Hamilton, Hilary; Gallagher, Paul; Ryan, Cristin; Byrne, Stephen; O'Mahony, Denis (13 June 2011). "Potentially Inappropriate Medications Defined by STOPP Criteria and the Risk of Adverse Drug Events in Older Hospitalized Patients". Arch Intern Med. 171 (11): 1013–1019. doi:10.1001/archinternmed.2011.215. PMID   21670370.
  7. ↑ Lee, Georgie; Lim, Joy-Francesca; Page, Amy T.; Etherton-Beer, Christopher; Clifford, Rhonda; Wang, Kate (2022). "Applicability of explicit potentially inappropriate medication lists to the Australian context: A systematic review". Australasian Journal on Ageing. 41 (2): 200–221. doi:10.1111/ajag.13038. ISSN   1741-6612. PMID   35025135. S2CID   245941385.
  8. ↑ Fick, DM; Cooper, JW; Wade, WE; Waller, JL; Maclean, JR; Beers, MH (2003). "Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts". Archives of Internal Medicine. 163 (22): 2716–2724. doi:10.1001/archinte.163.22.2716. PMID   14662625.
  9. ↑ American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015). "American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults". J Am Geriatr Soc. 63 (11): 2227–46. doi: 10.1111/jgs.13702 . PMID   26446832. S2CID   38797655.
  10. ↑ Louden, Kathleen (9 June 2015). "Geriatrics Society Updates List of Inappropriate Drugs". Medscape.
  11. ↑ "For Older People, Medications Are Common; Updated AGS Beers Criteria Aims to Make Sure They're Appropriate, Too". American Geriatrics Society.
  12. 1 2 By the 2023 American Geriatrics Society Beers Criteria® Update Expert Panel (2023-05-04). "American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults". Journal of the American Geriatrics Society. doi: 10.1111/jgs.18372 . ISSN   0002-8614. PMID   37139824. S2CID   258486318.
  13. ↑ "Newsletter of the American Geriatrics Society" (PDF). American Geriatrics Society. Vol. 49, no. 3. 2018.
  14. ↑ "CSIS Health Homepage". CSIS Health Corp.
  15. 1 2 3 American Geriatrics Society 2012 Beers Criteria Update Expert Panel (April 2012). "American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults". Journal of the American Geriatrics Society. 60 (4): 616–631. doi:10.1111/j.1532-5415.2012.03923.x. PMC   3571677 . PMID   22376048.
  16. ↑ "Clinical Practice Guidelines We Can Trust". Archived from the original on 22 July 2014.
  17. ↑ "American Geriatrics Society 2019 Updated AGS Beers Criteria®for Potentially Inappropriate Medication Use in Older Adults" (PDF). American Geriatrics Society Beers Criteria Update Expert Panel. Archived from the original (PDF) on 30 August 2020. Retrieved 27 September 2020.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.